Edgewise Therapeutics, Inc. (EWTX) - Quarterly Income Statement

Home
EWTX
Financials

15.24 (USD) • At close June 6, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	0	0	0	0	2.252	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	-1.059	0	0.534	0.525	0.533	0.448	0.437	0.241	0.092	0.165	0.154	0.127	0.078	0.064	0.051	0.079	0	0	0	0
Gross Profit Numbers are in millions	0	1.059	0	-0.534	-0.525	1.719	-0.448	-0.437	-0.241	-0.092	-0.165	-0.154	-0.127	-0.078	-0.064	-0.051	-0.079	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0	0.763	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	36.757	37.323	32.222	30.2	27.221	27.684	23.786	19.559	19.876	16.612	13.894	12.402	11.124	9.088	9.88	7.861	5.36	5.139	3.238	3.639	2.967
General & Administrative Expenses Numbers are in millions	9.202	9.17	8.21	7.427	7.059	6.178	5.666	5.78	5.828	5.467	4.368	4.089	3.702	3.734	3.196	2.599	1.497	1.205	0.405	0.318	0.281
Selling & Marketing Expenses Numbers are in millions	0	0.106	0	-0.054	-0.052	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	9.202	9.276	8.21	7.373	7.007	6.178	5.666	5.78	5.828	5.467	4.368	4.089	3.702	3.734	3.196	2.599	1.497	1.205	0.405	0.318	0.281
Other Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Expenses Numbers are in millions	45.959	46.599	40.432	37.573	34.228	33.862	29.452	25.339	25.704	22.079	18.262	16.491	14.826	12.822	13.076	10.46	6.857	6.344	3.643	3.957	3.248
Operating Income Numbers are in millions	-45.959	-45.54	-40.432	-38.107	-34.753	-33.862	-29.452	-25.339	-25.704	-22.079	-18.262	-16.491	-14.826	-12.822	-13.076	-10.46	-6.857	-6.344	-3.643	-3.957	-3.248
Operating Income Ratio Numbers are in millions	0	0	0	0	0	-15.036	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	5.161	5.878	6.303	6.61	6.228	3.719	3.739	3.87	2.866	2.664	0.764	0.424	0.166	0.126	0.127	0.107	0.042	0.002	0.001	0.003	0.063
Income Before Tax Numbers are in millions	-40.798	-39.662	-34.129	-31.497	-28.525	-30.143	-25.713	-21.469	-22.838	-19.415	-17.498	-16.067	-14.66	-12.696	-12.949	-10.353	-6.815	-6.342	-3.642	-3.954	-3.185
Income Before Tax Ratio Numbers are in millions	0	0	0	0	0	-13.385	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	-0.482	0	0	0.482	3.604	-0.497	0.339	-3.107	-2.664	-0.764	-0.424	-0.166	42.813	0	0	0	0	0	0	0
Net Income Numbers are in millions	-40.798	-39.662	-34.129	-31.497	-28.525	-30.143	-25.713	-21.469	-19.731	-16.751	-16.734	-15.643	-14.494	-12.696	-12.949	-10.353	-6.815	-6.342	-3.642	-3.954	-3.185
Net Income Ratio Numbers are in millions	0	0	0	0	0	-13.385	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.43	-0.42	-0.36	-0.34	-0.33	-0.47	-0.41	-0.34	-0.31	-0.26	-0.32	-0.32	-0.29	-0.26	-0.26	-0.21	-4.37	-0.31	-0.18	-0.19	-0.16
EPS Diluted Numbers are in millions	-0.43	-0.42	-0.36	-0.34	-0.33	-0.47	-0.41	-0.34	-0.31	-0.26	-0.32	-0.32	-0.29	-0.26	-0.26	-0.21	-4.37	-0.31	-0.18	-0.19	-0.16
EBITDA Numbers are in millions	-45.959	-47.095	-39.83	-37.627	-34.28	-33.379	-29.003	-24.915	-25.509	-21.991	-18.162	-16.394	-14.699	-12.744	-13.012	-10.409	-6.778	-6.294	-3.593	-3.912	-3.208
EBITDA Ratio Numbers are in millions	0	0	0	0	0	-14.822	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Edgewise Therapeutics, Inc.

NASDAQ:EWTX Add to watchlist

NASDAQ:EWTX